Results 101 to 110 of about 2,566,443 (193)
Impact of pegloticase on patient outcomes in refractory gout: current perspectives
Rita N Cunha,1 Renata Aguiar,1 Filipa Farinha2 1Rheumatology Department, Centro Hospitalar do Baixo Vouga, Aveiro, Portugal; 2Centre for Rheumatology, University College London, London, UK Abstract: Gout is currently the most frequent cause of ...
Cunha RN, Aguiar R, Farinha F
doaj
Moving urate-lowering therapy in gout beyond guideline recommendations
The 'treat-to target serum urate strategy' when using urate-lowering therapy has been recommended by most specialist rheumatology societies for many years. An alternative "treat-to-avoid-symptoms" in gout has been suggested, albeit without a clear definition of what this means and how it might be implemented in clinical trials or clinical practice ...
Lisa K Stamp, Nicola Dalbeth
openaire +2 more sources
A 58‐year‐old male with a history of gout presented with new‐onset neck pain. Dual‐energy CT revealed extensive urate crystal deposition in his cervical part and sternoclavicular joints, an uncommon manifestation.
Chenyang Zhang +3 more
doaj +1 more source
BACKGROUND: Systemic inflammatory diseases have been associated with increased risk of venous thromboembolism. We aimed to quantify the risk of venous thromboembolism in patients with gout, the most common inflammatory arthritis, and to assess how ...
Roddy, E +3 more
core +1 more source
Xanthine oxidase inhibitors, including allopurinol and febuxostat, are the first-line treatment of hyperuricemia. This meta-analysis investigated the association between urate-lowering therapy and all-cause mortality in different chronic diseases to ...
Marcin M. Nowak +3 more
doaj +1 more source
Background Gout treatment is suboptimal despite available therapy, with low levels of initiation and persistence of urate-lowering therapy (ULT) in many patients.
Goodyear-Smith F +3 more
core +1 more source
Lipid Lowering Therapy According to Clinical Outcomes in Elderly Population
A systematic review of statin therapy and other lipid lowering agents and their efficacies in regard to the elderly population. In this review, I have introduced lipid metabolism and storage in the body.
Issa, Rabeh
core
ACR: American College of Rheumatology; OR: odds ratio; CI: confidence interval; BSR: Brazilian Society of Rheumatology; CrCl: creatinine clearance. OR lower than 1 represents a reduced chance of concordance with the 2012 ACR gout guidelines.Multivariate ...
Geraldo da Rocha Castelar-Pinheiro (783431) +5 more
core +1 more source
Gout : its epidemiology and therapeutic effect of urate-lowering agent
Gout is chronic inflammatory arthritis characterised by monosodium urate crystal deposition in peripheral joints. The global prevalence of gout is increasing except Taiwan and the United States.
Tsoi, Man-fung, 蔡文峰
core
Utility of the Morisky Medication Adherence Scale in gout: a prospective study
CSL Tan,1 GG Teng,1,2 KJ Chong,2 PP Cheung,1,2 AYN Lim,1,2 HL Wee,3,4 A Santosa1,2 1University Medicine Cluster, Division of Rheumatology, National University Health System, 2Department of Medicine, Yong Loo Lin School of Medicine, 3Department of ...
Tan CSL +6 more
doaj

